Bergua Burgués, Juan Miguel | Hematología y Hemoterapia |

Resultados: 175
Tipo Título / Nombre Autor(es) Año
Bispecific T cell engager antibodies may contribute to reactivate pre-existing tumor specific T cells Primo D, Pérez Oteyza J, Bergua JM, Hernández Rivas JA, Ruiz E, Vives S 2020
The mode of action (MOA) of the anti-CD38 monoclonal antibody (MAB) Isatuximab in elderly acute myeloid leukemia Zabaleta A, Alameda D, Ajona C, Perez C, Alignani D, ..., Bergua JM 2020
Corrigendum to "Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study" [Leuk. Res. 92 (March) (2020) 106352] Rodríguez-Medina C, Martínez-Cuadrón D, Cano I, Gil C, Tormo M..., Bergua-Burgues JM 2020
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project Sargas C, Ayala R, Chillón MC, Larráyoz MJ, Carrillo-Cruz E..., Bergua J, [PETHEMA NGS-AML project] 2020
Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry Martínez P, Palanques Pastor T, López Lorenzo JL, Cornago Navascués J, Rodríguez Macías G, Cano I, Arnan Sangerman M, Vidriales MB, Algarra JL, Foncillas MA, Herrera Puente P, Botella C, Vives S, Figuera Álvarez A, Cuevas Palomares L, Sobas M, Contento Gonzalo A, Cuello R, Amutio Díez E, Miguel MD de, Navas B, Bergua Burgues JM 2020
Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry Labrador J, Martínez Cuadrón D, Fuente A de la, Rodríguez Veiga R, Serrano J, Tormo M, Pérez Simón JA, Bernal del Castillo T, López Pavía M, Trigo F, Martínez Sánchez P, Rodríguez Gutiérrez JI, Gil C, García D, Vives S, Foncillas MA, Bergua Burgues JM, Noriega Concepción V, Lavilla E, Roldán Pérez A, Sanz MA, Montesinos P 2020
Biomarker-Driven Phase Ib Clinical Trial of OPB-111077 in Acute Myeloid Leukemia Increases Overall Response Rates Martínez López J, Montesinos P, Martínez Sánchez P, Gorrochategui J, Rojas JL, Prino D, Bergua JM, Ayala RM, Calbacho M, López Muñoz N, Acuña E, Pérez Simón JA, Fuente A de la, Pérez de Oteyza J, Rodríguez Veiga R, Boluda B, Cano I, Ballesteros J 2020
Measurable Residual Disease (MRD) in Elderly Acute Myeloid Leukemia (AML): Results from the Pethema-Flugaza Phase III Clinical Trial Simoes CP, Paiva B, Martínez Cuadron D, Bergua JM, Vives S, Algarra JL, Tormo M, Martinez P, Serrano J, Herrera P 2020
Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia Valhondo I, Hassouneh F..., Bergua JM, Arcos MJ, Bañas H, Casas-Avilés I, Sánchez-García J, Serrano J, Duran E, Alonso C, Solana R, Tarazona R 2020
Antithrombotic treatment in patients with factor VII deficiency: case reports Moriano B, Bermejo N, Rodríguez A, Espina M, Espina M, Ramos L, Arcos MJ, Bañas H, Carnicero F, Cardesa R, Casas I, Ferre O, Cáceres S, Ibañez F, Cabrera C, Bergua J 2020